Chimerix files FDA application for brain cancer treatment – Triangle Business Journal
The Durham company is seeking a fast track to regulatory approval for its brain cancer treatment.
FDA Approves Datroway for Pretreated Advanced Breast Cancer
In trial, datopotamab deruxtecan increased progression-free survival by 2 months
A tiny anticancer weapon: Nano-sized particles trigger tumor cell self-destruction
A new twist on a decades-old anticancer strategy has shown powerful effects against multiple cancer types in a preclinical study from researchers in the Perelman School of Medicine at the University of Pennsylvania.
Omitting Axillary Lymph Node Dissection in Early Breast Cancer
Two large trials, real-world data inform clinical decision-making
